Green Cross to release Hyalobarrier gel

Published: 2010-04-07 06:58:00

Updated: 2010-04-07 06:58:00

Green Cross Corporation said on April 4 that Hyalobarrier gel will be available in Korea under the exclusive distribution agreement with the US based FAB/Anika Therapeutic.

Hyalobarrier gel is the highly advanced bio-technology specialty product used for the prevention of post-surgical adhesi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK